DAWN Competitors & Alternatives
Compare Day One Biopharmaceuticals Inc with similar stocks in the same industry
Biotechnology
DAWN
Main Stock$21.53
Tradestie Score
59
Market Cap
$704.73M
Revenue Growth
0.8%
Analyst Upside
-0.1%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$133.54
|
$2.35B | - | 60 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$8.76
|
$2.34B | - | 61 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$79.76
|
$2.33B | - | 66 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$44.01
|
$2.33B | - | 57 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 59 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.84
|
$2.23B | - | 62 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$20.82
|
$2.22B | - | 64 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$57.85
|
$2.21B | - | 56 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$26.31
|
$2.18B | - | 59 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$14.29
|
$2.08B | - | 54 | Compare |
More DAWN Analysis
Data updated: Jul 08, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry